LH vs. ABT
Compare and contrast key facts about Laboratory Corporation of America Holdings (LH) and Abbott Laboratories (ABT).
Performance
LH vs. ABT - Performance Comparison
Loading graphics...
LH vs. ABT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LH Laboratory Corporation of America Holdings | 6.62% | 10.62% | 2.22% | 13.82% | -24.41% | 54.37% | 20.32% | 33.88% | -20.78% | 24.25% |
ABT Abbott Laboratories | -17.64% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
Fundamentals
LH:
$22.20B
ABT:
$179.36B
LH:
$10.48
ABT:
$3.73
LH:
25.47
ABT:
27.52
LH:
1.60
ABT:
4.05
LH:
2.58
ABT:
3.44
LH:
$13.95B
ABT:
$44.33B
LH:
$4.01B
ABT:
$24.61B
LH:
$1.86B
ABT:
$11.33B
Returns By Period
In the year-to-date period, LH achieves a 6.62% return, which is significantly higher than ABT's -17.64% return. Over the past 10 years, LH has underperformed ABT with an annualized return of 10.65%, while ABT has yielded a comparatively higher 11.37% annualized return.
LH
- 1D
- 1.21%
- 1M
- -7.72%
- YTD
- 6.62%
- 6M
- -6.57%
- 1Y
- 15.87%
- 3Y*
- 11.98%
- 5Y*
- 5.22%
- 10Y*
- 10.65%
ABT
- 1D
- 0.78%
- 1M
- -11.76%
- YTD
- -17.64%
- 6M
- -22.62%
- 1Y
- -21.15%
- 3Y*
- 2.45%
- 5Y*
- -1.11%
- 10Y*
- 11.37%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LH vs. ABT — Risk / Return Rank
LH
ABT
LH vs. ABT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LH | ABT | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.63 | -0.92 | +1.55 |
Sortino ratioReturn per unit of downside risk | 1.04 | -1.12 | +2.17 |
Omega ratioGain probability vs. loss probability | 1.13 | 0.84 | +0.29 |
Calmar ratioReturn relative to maximum drawdown | 1.13 | -0.80 | +1.93 |
Martin ratioReturn relative to average drawdown | 2.73 | -2.02 | +4.74 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LH | ABT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.63 | -0.92 | +1.55 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.23 | -0.05 | +0.28 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.48 | -0.08 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.18 | 0.41 | -0.23 |
Correlation
The correlation between LH and ABT is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
LH vs. ABT - Dividend Comparison
LH's dividend yield for the trailing twelve months is around 1.08%, less than ABT's 2.34% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LH Laboratory Corporation of America Holdings | 1.08% | 1.15% | 1.26% | 1.18% | 0.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABT Abbott Laboratories | 2.34% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
Drawdowns
LH vs. ABT - Drawdown Comparison
The maximum LH drawdown since its inception was -96.15%, which is greater than ABT's maximum drawdown of -55.57%. Use the drawdown chart below to compare losses from any high point for LH and ABT.
Loading graphics...
Drawdown Indicators
| LH | ABT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.15% | -55.57% | -40.58% |
Max Drawdown (1Y)Largest decline over 1 year | -15.22% | -25.18% | +9.96% |
Max Drawdown (5Y)Largest decline over 5 years | -34.61% | -33.88% | -0.73% |
Max Drawdown (10Y)Largest decline over 10 years | -46.58% | -33.88% | -12.70% |
Current DrawdownCurrent decline from peak | -7.81% | -25.41% | +17.60% |
Average DrawdownAverage peak-to-trough decline | -29.71% | -14.29% | -15.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.32% | 9.94% | -3.62% |
Volatility
LH vs. ABT - Volatility Comparison
Laboratory Corporation of America Holdings (LH) and Abbott Laboratories (ABT) have volatilities of 6.01% and 5.95%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LH | ABT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.01% | 5.95% | +0.06% |
Volatility (6M)Calculated over the trailing 6-month period | 17.15% | 16.83% | +0.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.29% | 23.14% | +2.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.21% | 21.98% | +1.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.53% | 23.57% | +2.96% |
Financials
LH vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Laboratory Corporation of America Holdings and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LH vs. ABT - Profitability Comparison
LH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Laboratory Corporation of America Holdings reported a gross profit of 993.20M and revenue of 3.52B. Therefore, the gross margin over that period was 28.3%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a gross profit of 6.54B and revenue of 11.46B. Therefore, the gross margin over that period was 57.1%.
LH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Laboratory Corporation of America Holdings reported an operating income of 267.60M and revenue of 3.52B, resulting in an operating margin of 7.6%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported an operating income of 2.25B and revenue of 11.46B, resulting in an operating margin of 19.6%.
LH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Laboratory Corporation of America Holdings reported a net income of 164.70M and revenue of 3.52B, resulting in a net margin of 4.7%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Abbott Laboratories reported a net income of 1.78B and revenue of 11.46B, resulting in a net margin of 15.5%.